Ariceum Therapeutics

Ariceum Therapeutics Appoints Chief Business Officer

BERLIN, 7 July 2022 - Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and systemic targeted radiation therapy of certain hard-to-treat cancers, is pleased to announce the appointment of Serge Sagodira as Chief Business Officer. Appointed from 1 July 2022, Serge will oversee all business development aspects of the company,...
Robert-Rössle-Straße. 10 Building 79 13125 Berlin